PREDICTION OF COGNITIVE DECLINE W/ MRI & MRS
通过 MRI 预测认知能力下降
基本信息
- 批准号:8171038
- 负责人:
- 金额:$ 0.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-08-01 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseApolipoprotein EAtrophicBrainClinical dementia rating scaleCognitiveComputer Retrieval of Information on Scientific Projects DatabaseDementiaFundingFutureGeneticGoalsGrantHippocampus (Brain)Impaired cognitionInstitutionMagnetic Resonance ImagingMeasuresMemoryMetabolicMetabolismMethodsParietal LobePatternPerfusionPredictive ValuePrimary PreventionResearchResearch PersonnelResourcesScanningSourceStructureTechniquesTestingTimeUnited States National Institutes of Healthcognitive functionentorhinal cortexexecutive functiongray matterhigh riskimprovedresearch clinical testing
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The overall goal of this project is to determine the pattern of longitudinal structural, perfusion, and metabolic changes in the brain, which best predict future cognitive decline and dementia due to Alzheimer's disease (AD). Specifically we will determine the predictive "value added" of MRI/MRS to cognitive testing. We will perform longitudinal clinical evaluation, cognitive testing, and MRI/MRS studies on 130 completed non-demented subjects 65 yr, presenting with memory complaints. The independent variables will be obtained from MRI/MRS at 0, 6, 12,and 24 mo. to measure brain structure, perfusion, and metabolism. Dependent variables will be decline of memory and executive function scores, assessed annually. Clinical dementia rating scale and conversion to dementia will be used as secondary dependent variables. The overall hypothesis is that MRI/MRSI predicts cognitive decline/dementia. Hypotheses: 1.) Initial entorhinal cortex (ERC) volume predicts cognitive decline/dementia and ad ds to the predictive value of baseline memory function. 2.) In addition to baseline memory function and ERC volume, rate of ERC atrophy improves prediction of cognitive decline. 3.) The best MRI predictors for memory decline are volume change over time of ERC and hippocampus, and these add to the predictive value of baseline memory function. The best predictors of executive function decline are volume changes in frontal gray matter and these add to the predictive value of baseline cognitive function. 4.) In addition to baseline memory function and changes of ERC volume, perfusion and metabolite (NAA, mI) changes over time in hippocampus temporal and parietal lobe further improve prediction of cognitive decline. In addition to the above hypotheses, we will explore what combination of cognitive, genetic (APOE) and MRI/MRS measures, and what between-scan interval, best predicts subsequent cognitive decline/dementia. This project is expected to improve methods for predicting cognitive decl ine/dementia due to AD; these techniques should identify those subjects at high risk for AD, who are candidates for primary prevention.
该子项目是利用该技术的众多研究子项目之一
资源由 NIH/NCRR 资助的中心拨款提供。子项目和
研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金,
因此可以在其他 CRISP 条目中表示。列出的机构是
对于中心来说,它不一定是研究者的机构。
该项目的总体目标是确定大脑纵向结构、灌注和代谢变化的模式,从而最好地预测未来因阿尔茨海默病 (AD) 引起的认知能力下降和痴呆。具体来说,我们将确定 MRI/MRS 对认知测试的预测“附加值”。我们将对 130 名 65 岁、有记忆抱怨的完整非痴呆受试者进行纵向临床评估、认知测试和 MRI/MRS 研究。自变量将从 0、6、12 和 24 个月时的 MRI/MRS 获得。测量大脑结构、灌注和新陈代谢。因变量是每年评估的记忆力下降和执行功能评分。临床痴呆评定量表和痴呆转化率将用作次要因变量。总体假设是 MRI/MRSI 可以预测认知能力下降/痴呆。假设: 1.) 初始内嗅皮层 (ERC) 体积可预测认知能力下降/痴呆,并增加基线记忆功能的预测价值。 2.) 除了基线记忆功能和 ERC 体积之外,ERC 萎缩率还可以提高对认知能力下降的预测。 3.) 记忆力下降的最佳 MRI 预测指标是 ERC 和海马体的体积随时间的变化,这些增加了基线记忆功能的预测价值。执行功能下降的最佳预测因素是额叶灰质的体积变化,这些变化增加了基线认知功能的预测价值。 4.) 除了基线记忆功能和 ERC 体积的变化之外,海马颞叶和顶叶的灌注和代谢物(NAA、mI)随时间的变化进一步改善了对认知衰退的预测。除了上述假设之外,我们还将探讨认知、遗传 (APOE) 和 MRI/MRS 测量的哪种组合以及扫描间隔如何最能预测随后的认知衰退/痴呆。该项目有望改进预测 AD 所致认知能力下降/痴呆的方法;这些技术应该能够识别出 AD 高危人群,他们是一级预防的候选者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL W WEINER其他文献
MICHAEL W WEINER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL W WEINER', 18)}}的其他基金
The Brain Health Registry for facilitating interdisciplinary aging research
促进跨学科衰老研究的脑健康登记处
- 批准号:
10360682 - 财政年份:2020
- 资助金额:
$ 0.91万 - 项目类别:
The Brain Health Registry for facilitating interdisciplinary aging research
促进跨学科衰老研究的脑健康登记处
- 批准号:
9895215 - 财政年份:2020
- 资助金额:
$ 0.91万 - 项目类别:
The Mobile Toolbox for Monitoring Cognitive Function - Project
用于监测认知功能的移动工具箱 - 项目
- 批准号:
10212850 - 财政年份:2018
- 资助金额:
$ 0.91万 - 项目类别:
The Mobile Toolbox for Monitoring Cognitive Function - Project
用于监测认知功能的移动工具箱 - 项目
- 批准号:
10454847 - 财政年份:2018
- 资助金额:
$ 0.91万 - 项目类别:
Longitudinal assessment of Gulf War veterans with suspected Sarin exposure
对疑似接触沙林的海湾战争退伍军人进行纵向评估
- 批准号:
8581089 - 财政年份:2013
- 资助金额:
$ 0.91万 - 项目类别:
Resource for MRI of Neurodegenerative Disorders
神经退行性疾病 MRI 资源
- 批准号:
7891998 - 财政年份:2009
- 资助金额:
$ 0.91万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 0.91万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 0.91万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 0.91万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 0.91万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 0.91万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 0.91万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 0.91万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 0.91万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 0.91万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 0.91万 - 项目类别:














{{item.name}}会员




